PULIKE BIOLOGICAL ENGINEERING,INC.PULIKE BIOLOGICAL ENGINEERING,INC.PULIKE BIOLOGICAL ENGINEERING,INC.

PULIKE BIOLOGICAL ENGINEERING,INC.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.31 B‬CNY
0.30CNY
‪174.52 M‬CNY
‪1.24 B‬CNY
‪190.07 M‬
Beta (1Y)
1.46
Employees (FY)
‪1.68 K‬
Change (1Y)
−39 −2.27%
Revenue / Employee (1Y)
‪103.86 K‬CNY
Net income / Employee (1Y)
‪14.64 K‬CNY

About PULIKE BIOLOGICAL ENGINEERING,INC.


CEO
Fei Hu
Headquarters
Luoyang
Founded
1995
ISIN
CNE1000025N0
FIGI
BBG002WTM467
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. Its products include genetic engineering vaccines and multivalent vaccines. The company also provides technical services. Pulike Biological Engineering was founded in 1995 and is headquartered in Luoyang, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 603566 is 12.70 CNY — it has decreased by −4.80% in the past 24 hours. Watch PULIKE BIOLOGICAL ENGINEERING,INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange PULIKE BIOLOGICAL ENGINEERING,INC. stocks are traded under the ticker 603566.
603566 stock has fallen by −2.83% compared to the previous week, the month change is a −1.78% fall, over the last year PULIKE BIOLOGICAL ENGINEERING,INC. has showed a −41.23% decrease.
We've gathered analysts' opinions on PULIKE BIOLOGICAL ENGINEERING,INC. future price: according to them, 603566 price has a max estimate of 15.25 CNY and a min estimate of 15.00 CNY. Watch 603566 chart and read a more detailed PULIKE BIOLOGICAL ENGINEERING,INC. stock forecast: see what analysts think of PULIKE BIOLOGICAL ENGINEERING,INC. and suggest that you do with its stocks.
603566 reached its all-time high on Jun 12, 2015 with the price of 43.24 CNY, and its all-time low was 10.58 CNY and was reached on Oct 19, 2018. View more price dynamics on 603566 chart.
See other stocks reaching their highest and lowest prices.
603566 stock is 5.60% volatile and has beta coefficient of 1.46. Track PULIKE BIOLOGICAL ENGINEERING,INC. stock price on the chart and check out the list of the most volatile stocks — is PULIKE BIOLOGICAL ENGINEERING,INC. there?
Today PULIKE BIOLOGICAL ENGINEERING,INC. has the market capitalization of ‪4.36 B‬, it has increased by 2.62% over the last week.
Yes, you can track PULIKE BIOLOGICAL ENGINEERING,INC. financials in yearly and quarterly reports right on TradingView.
PULIKE BIOLOGICAL ENGINEERING,INC. is going to release the next earnings report on Apr 25, 2025. Keep track of upcoming events with our Earnings Calendar.
603566 net income for the last quarter is ‪32.33 M‬ CNY, while the quarter before that showed ‪46.64 M‬ CNY of net income which accounts for −30.69% change. Track more PULIKE BIOLOGICAL ENGINEERING,INC. financial stats to get the full picture.
PULIKE BIOLOGICAL ENGINEERING,INC. dividend yield was 3.09% in 2023, and payout ratio reached 138.67%. The year before the numbers were 1.28% and 67.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has ‪1.68 K‬ employees. See our rating of the largest employees — is PULIKE BIOLOGICAL ENGINEERING,INC. on this list?
Like other stocks, 603566 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PULIKE BIOLOGICAL ENGINEERING,INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PULIKE BIOLOGICAL ENGINEERING,INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PULIKE BIOLOGICAL ENGINEERING,INC. stock shows the sell signal. See more of PULIKE BIOLOGICAL ENGINEERING,INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.